'United Kingdom', 'British takeover law', 'prohibit.01', 'the U.S. firm', 'from sweetening', 'Affirmative', "'s $ 117 billion pursuit of British drugmaker AstraZeneca PLC is likely to fail because British takeover law prohibits the U.S. firm from sweetening its offer after declaring it final , according to people familiar with the transaction . ", 'United States', 'newsText6985'
